Sam Chun Dang Pharm. Co., Ltd (000250.KQ)
KRW 114400.0
(-4.75%)
KRW 114400.0
(-4.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.42 Billion | 13.27 Billion | -7.21 Billion | 610.38 Million | 31.9 Billion | 23.61 Billion |
| Net Income | -10.38 Billion | 5.83 Billion | -16.55 Billion | -965.67 Million | 10.45 Billion | 8.75 Billion |
| Depreciation & Amortization | 8.43 Billion | 7.65 Billion | 6.74 Billion | 6.68 Billion | 6.49 Billion | 6.3 Billion |
| Deferred income taxes | -25.73 Billion | - | - | - | - | - |
| Stock-based compensation | 81.4 Million | - | - | - | - | - |
| Change in working capital | 726.08 Million | -10.42 Billion | -2.71 Billion | -8.04 Billion | -2.56 Billion | 488.67 Million |
| Other non-cash items | 50.35 Billion | 37.95 Billion | 18.84 Billion | 21.58 Billion | 29.8 Billion | 16.95 Billion |
| Investing Cash Flow | -8.42 Billion | -53.93 Billion | -30.05 Billion | -19.2 Billion | -19.33 Billion | -50.27 Billion |
| Investments in PPE | -21.97 Billion | -46.54 Billion | -29.3 Billion | -11.79 Billion | -10.15 Billion | -19.96 Billion |
| Acquisitions | 683.79 Million | 1.29 Billion | 6.9 Million | 29.8 Million | 800 Thousand | 190.7 Million |
| Investment purchases | -48 Billion | -73.35 Billion | -66 Billion | -86.44 Billion | -39.09 Billion | -34.44 Billion |
| Sales/Maturities of investments | 63.45 Billion | 65 Billion | 64.28 Billion | 82.43 Billion | 29.29 Billion | 4.23 Billion |
| Other Investing Activities | -2.58 Billion | -337.82 Million | 968.91 Million | -3.43 Billion | 624.88 Million | -296.71 Million |
| Financing Cash Flow | 3.38 Billion | 13.32 Billion | 27.69 Billion | 14.66 Billion | -2.41 Billion | 14.8 Billion |
| Debt repayment | -5.47 Billion | -21.17 Billion | -29.56 Billion | -19.57 Billion | -227.4 Million | -16.87 Billion |
| Dividends payments | -880.82 Million | -968.35 Million | -968.35 Million | -1.07 Billion | -1.07 Billion | -1.07 Billion |
| Common Stock Repurchased | - | -5.95 Billion | - | -2.02 Billion | - | - |
| Common Stock Issuance | -99.46 Thousand | 6.88 Billion | - | 2.82 Billion | - | - |
| Other Financing Activities | -880.82 Million | -968.35 Million | -10.00 | -1.01 Billion | -996.7 Million | -996.7 Million |
| Accounts receivables | 3.2 Billion | -3.47 Billion | -2.35 Billion | 4.12 Billion | 1.32 Billion | 1.08 Billion |
| Accounts payables | -6.29 Billion | -3.69 Billion | 4.58 Billion | -5.39 Billion | 1 Billion | 4.19 Billion |
| Inventory | -5.75 Billion | -5.28 Billion | -2.28 Billion | -3.99 Billion | -1.62 Billion | -1.56 Billion |
| Other working capital | 9.56 Billion | 2.02 Billion | -2.67 Billion | -2.77 Billion | -3.26 Billion | -3.22 Billion |
| Cash at beginning of period | 22.1 Billion | 49.11 Billion | 58.93 Billion | 60.27 Billion | 51.47 Billion | 61.9 Billion |
| Cash at end of period | 40.42 Billion | 22.1 Billion | 49.11 Billion | 58.93 Billion | 60.27 Billion | 51.47 Billion |
| Capital Expenditure | -21.97 Billion | -46.54 Billion | -29.3 Billion | -11.79 Billion | -10.15 Billion | -19.96 Billion |
| Effect of forex changes on cash | -66.66 Million | 321.18 Million | 243.94 Million | -42.62 Million | -46.82 Million | -5.31 Million |
| Net cash flow / Change in cash | 18.32 Billion | -27.01 Billion | -9.82 Billion | -1.33 Billion | 8.8 Billion | -10.43 Billion |
| Free Cash Flow | 1.45 Billion | -33.26 Billion | -36.52 Billion | -11.18 Billion | 21.74 Billion | 3.65 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 174.06 Million | 1.13 Billion | 4.9 Billion | -10.38 Billion | -11.81 Billion | -3.83 Billion |
| Depreciation & Amortization | 2.29 Billion | 2.05 Billion | 2.07 Billion | 8.43 Billion | 2.03 Billion | 2.15 Billion |
| Deferred income taxes | - | - | -1.21 Billion | -25.73 Billion | -8.26 Billion | - |
| Stock-based compensation | 129.44 Million | 162.14 Million | -416.12 Million | 81.4 Million | 127.15 Million | - |
| Change in working capital | -1.29 Billion | -3.24 Billion | 15.67 Billion | 726.08 Million | -3.99 Billion | -4.92 Billion |
| Other non-cash items | 8.62 Billion | 9.68 Billion | -1.69 Billion | 50.35 Billion | 23.23 Billion | 16.36 Billion |
| Investing Cash Flow | 6.12 Billion | 6.29 Billion | 10.26 Billion | -8.42 Billion | -5.37 Billion | -614.09 Million |
| Investments in PPE | -2.97 Billion | -3.54 Billion | -5.2 Billion | -21.97 Billion | -5.35 Billion | -5.69 Billion |
| Acquisitions | 8.24 Million | 9.81 Million | - | 683.79 Million | - | - |
| Investment purchases | -12.95 Billion | -2.8 Billion | -10.06 Billion | -48 Billion | -11.43 Billion | 6.01 Billion |
| Sales/Maturities of investments | 26.53 Billion | 12.62 Billion | 27.49 Billion | 63.45 Billion | 11 Billion | 4.59 Million |
| Other Investing Activities | 9.09 Billion | -2.78 Billion | -1.96 Billion | -2.58 Billion | 414.62 Million | -931.1 Million |
| Financing Cash Flow | 36.9 Billion | -253.03 Million | -14.92 Billion | 3.38 Billion | -452.03 Million | -981.16 Million |
| Debt repayment | -10.3 Billion | -152.26 Million | -14.58 Billion | -5.47 Billion | -123.81 Million | -117.46 Million |
| Dividends payments | -890.15 Million | - | -880.82 Million | -880.82 Million | - | -880.82 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 37.56 Billion | - | -14.29 Thousand | -99.46 Thousand | -23.21 Thousand | - |
| Other Financing Activities | 48.1 Billion | 152.26 Million | -880.82 Million | -880.82 Million | -23.2 Thousand | -10.00 |
| Accounts receivables | -3.74 Billion | 260.58 Million | 5.78 Billion | 3.2 Billion | -1.55 Billion | -354.9 Million |
| Accounts payables | 5.26 Billion | 273.13 Million | -2.8 Billion | -6.29 Billion | 601.5 Million | -513.61 Million |
| Inventory | -2.06 Billion | -3.88 Billion | 2.1 Billion | -5.75 Billion | -3.12 Billion | -3.23 Billion |
| Other working capital | 4.51 Billion | 101.71 Million | 10.6 Billion | 9.56 Billion | 76.94 Million | -817.86 Million |
| Cash at beginning of period | 48.98 Billion | 40.42 Billion | 23.42 Billion | 22.1 Billion | 27.88 Billion | 28.12 Billion |
| Cash at end of period | 102.02 Billion | 48.98 Billion | 40.42 Billion | 40.42 Billion | 23.42 Billion | 27.88 Billion |
| Capital Expenditure | -2.97 Billion | -3.54 Billion | -5.2 Billion | -21.97 Billion | -5.35 Billion | -5.69 Billion |
| Effect of forex changes on cash | 97.6 Million | 343.99 Million | -230.87 Million | -66.66 Million | 51.77 Million | 8.97 Million |
| Net cash flow / Change in cash | 53.04 Billion | 8.55 Billion | 17 Billion | 18.32 Billion | -4.46 Billion | -237.98 Million |
| Free Cash Flow | 6.94 Billion | -1.37 Billion | 16.68 Billion | 1.45 Billion | -4.04 Billion | -4.34 Billion |
ZENOTECH
MHUB
PANCHSHEEL
BWG
SHAMROIN
CCJ